anti-Clostridium difficile mAbs (Mapp Biopharmaceutical)

N/A

Report date: 2025/03/14 16:51:43

Base Information

Drug Nameanti-Clostridium difficile mAbs (Mapp Biopharmaceutical)

Drug Alias Nameanti-Clostridium difficile monoclonal antibodies (Mapp Biopharmaceutical/University of Arizona)anti-Clostridium difficile mAbs (Mapp Biopharmaceutical/University of Arizona)

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human

Mechanisms of ActionToxin B inhibitorsToxin A inhibitors

TargetsToxin BToxin A

Therapy Area/IndicationsClostridium Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesMapp Biopharmaceutical Inc

China Registration ClassN/A

Develop Information

Active CompaniesMapp Biopharmaceutical Inc

Inactive CompaniesThe University Of Arizona

Active IndicationsClostridium Infections

Inactive IndicationsN/A

Other Information

ATC CodeN/A